MIR4529

gene
On this page

Also known as hsa-mir-4529

Summary

MIR4529 (microRNA 4529, HGNC:41703) is a microRNA gene on chromosome 18q21.2.

microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.

Source: NCBI Gene 100616290 — RefSeq curated summary.

At a glance

  • Gene type: non-coding (miRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:41703
Approved symbolMIR4529
NamemicroRNA 4529
Location18q21.2
Locus typeRNA, micro
StatusApproved
Aliaseshsa-mir-4529
Ensembl geneENSG00000264571
Ensembl biotypemiRNA
Entrez100616290
RNAcentralURS000075CE31 — miRNA, 78 nt, 3 organism(s)

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 miRNA

ENST00000578110

RefSeq mRNA: 0 — MANE Select: None

Canonical transcript exons

ENST00000578110 — 1 exons

ExonStartEnd
ENSE000027295245547922155479298

Expression profiles

Bgee: expression breadth broad, 32 present calls, max score 81.32.

Top tissues by expression

32 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
adrenal glandUBERON:000236981.32gold quality
adrenal tissueUBERON:001830380.19gold quality
calcaneal tendonUBERON:000370179.16gold quality
nucleus accumbensUBERON:000188277.46gold quality
monocyteCL:000057674.82gold quality
stomachUBERON:000094573.58gold quality
gastrocnemiusUBERON:000138872.31gold quality
lungUBERON:000204870.41gold quality
esophagus mucosaUBERON:000246966.68gold quality
tibial arteryUBERON:000761066.17gold quality
intestineUBERON:000016066.09gold quality
upper lobe of left lungUBERON:000895264.86gold quality
ascending aortaUBERON:000149664.56gold quality
heart left ventricleUBERON:000208464.38gold quality
transverse colonUBERON:000115764.10gold quality
esophagogastric junction muscularis propriaUBERON:003584163.97gold quality
skin of abdomenUBERON:000141663.66gold quality
putamenUBERON:000187463.59gold quality
amygdalaUBERON:000187663.44gold quality
right ovaryUBERON:000211863.34gold quality
prostate glandUBERON:000236763.06gold quality
thoracic mammary glandUBERON:000520063.02gold quality
lower esophagus muscularis layerUBERON:003583362.88gold quality
vaginaUBERON:000099660.98gold quality
dorsolateral prefrontal cortexUBERON:000983459.15gold quality
left ovaryUBERON:000211958.90gold quality
muscle layer of sigmoid colonUBERON:003580558.85gold quality
right hemisphere of cerebellumUBERON:001489058.75gold quality
cerebellar hemisphereUBERON:000224558.29gold quality
Brodmann (1909) area 9UBERON:001354057.12gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no0.64

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 1)

  • miR-4529-3p Promotes the Progression of Retinoblastoma by Inhibiting RB1 Expression and Activating the ERK Signaling Pathway. (PMID:37041423)

Cross-species orthologs

0 orthologs

Protein

Non-coding RNA — no protein product; not a drug target.

Function

No curated pathway, Gene-Ontology, or interaction data.

Disease & clinical

No curated disease, variant, or cancer-driver associations.

Drugs & pharmacology

No drug or pharmacology data — not an established drug target.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.